1. Introduction {#s0005}
===============

Protozoan parasites of the genus *Leishmania* cause a wide range of diseases affecting 12 million people worldwide with 1.5--2 million new cases each year ([@b0100]). With no vaccine available yet, the control of these parasites relies solely on chemotherapy. The first-line of treatment relies on pentavalent antimony (SbV) compounds ([@b0010]). However, in certain regions such as Bihar state in India, resistance to SbV is now widespread and alternative drugs must be used ([@b0080; @b0155; @b0165]). Alternative drugs such as paromomycin ([@b0160]) and the orally administered miltefosine ([@b0150]) are effective and used against *Leishmania*. Nowadays, liposomal AmB is considered as the best drug available against visceral leishmaniasis, the most severe form of the disease that is fatal if untreated ([@b0015; @b0050]). However, its high cost limits its widespread use in developing countries ([@b0105]).

Clinical resistance to AmB is rare as shown by the absence of resistance in strains isolated from HIV-1 patients treated repeatedly with AmB ([@b0075]) although few unusual cases have been reported recently in India ([@b0145; @b0115]). The molecular mechanisms of AmB resistance are not very well understood. *In vitro* generated AmB resistant mutants showed that ergosterol in the plasma membrane was replaced by a precursor, cholesta-5,7,24-trien-3β-ol, which prevents the binding and subsequent uptake of the drug ([@b0085]). The same substitution was observed in clinical resistant strains along with a higher expression level of the ABC transporter MDR1 (ABCB4) and of some enzymes involved in thiol metabolism ([@b0115]).

Quantitative proteomics is now emerging as a powerful approach to study drug resistance in microorganisms. Here, we used the stable isotope labeling of amino acids in cell culture (SILAC) methodology to study AmB resistance in *Leishmania*. The present paper reports for the first time the use of a large-scale quantitative proteomic study to characterize the proteome of an *in vitro* selected AmB resistant *Leishmania* mutant.

2. Material and methods {#s0010}
=======================

2.1. Cell culture and SILAC {#s0015}
---------------------------

The *Leishmania infantum* (MHOM/MA/67/ITMAP-263) wild-type (WT) strain and the *in vitro* generated resistant mutant AmB1000.1, which is resistant to 1000 nM of AmB, were described previously ([@b0090]). The resistance phenotype to AmB was tested after 7 and 63 passages in absence of drug and has been proven to be highly stable in this mutant. For SILAC experiments, we first did an incorporation assay on WT cells to evaluate the extent of isotopic incorporation and technical noise. This control experiment allowed us to confirm that 99% of incorporation in lysine and arginine amino acids was achieved. Thus, promastigotes of WT and mutant AmB1000.1 were grown in RPMI-1640 medium for SILAC (minus [l]{.smallcaps}-lysine and [l]{.smallcaps}-arginine) (Cambridge Isotope Laboratories) supplemented with 75 μM adenosine (Sigma), 28 mM HEPES (Sigma), 40 μM biotin (Sigma), 1% penicillin--streptomycin (Wisent), 5 mg/L hemin (MP Biomedicals), 10 μM biopterin and 10% heat-inactivated dialysed foetal bovine serum (Cambridge Isotope Laboratories). *L. infantum* WT light medium (normal isotopic abundance) was also supplemented with 242.26 mg/L [l]{.smallcaps}-arginine (Sigma) and 50.03 mg/L [l]{.smallcaps}-lysine, while 253.68 mg/L ^13^C~6~-^15^N~4~-[l]{.smallcaps}-arginine and 62.21 mg/L ^13^C~6~-^15^N~2~-[l]{.smallcaps}-lysine were added to the resistant mutant heavy medium. Mutant cells were grown in the heavy complete medium for at least 7 passages to ensure a minimum of 99% incorporation of heavy isotopes into proteins, as previously determined in our control incorporation assay. WT and mutant cells were counted using a haemocytometer and the resistant strain was then mixed with WT cells in a 1:1 ratio.

2.2. Sample preparation {#s0020}
-----------------------

The membrane-enriched (ME) fraction was obtained by sonication, ultracentrifugation and further purification by Free flow zone electrophoresis (ZE-FFE) as described previously ([@b0040]). The cytosolic protein extraction was performed in 2D lysis buffer as described previously ([@b0035]). Proteins were then quantified using the 2D Quant kit (GE Healthcare).

2.3. Sodium dodecyl sulfate (SDS)-PAGE (1DE) {#s0025}
--------------------------------------------

Protein samples (30 μg) were mixed with 4× premixed protein sample buffer (BioRad) and β-mercaptoethanol (5% final concentration, Sigma), and heated at 95 °C for 5 min. Protein mixtures were then loaded on Precast Criterion XT Bis--Tris gradient gels (4--12% polyacrylamide, BioRad) and the SDS--PAGE separation was performed on a Criterion™ gel electrophoresis cell (BioRad) using a PowerPac 200 BioRad power supply set at 200 V for 50 min. For staining, gels were fixed in a solution of 50% methanol: 7.5% acetic acid for 1 h then incubated overnight with SYPRO Ruby Protein Gel stain (BioRad). The destaining step was performed for 30 min in a solution of 15% methanol: 7.5% acetic acid. Gel images were captured on a PerkinElmer ProExpress Proteomic Imaging system. Each sample lane from the SDS--PAGE gels was cut in 40 fractions (24 fractions above 50 kDa and 16 fractions below 50 kDa) with disposable blade (MEE-1×5) mounted on a One Touch GridCutter (Gel Company Inc.).

2.4. Protein in-gel digestion {#s0030}
-----------------------------

Bands of interest were extracted from SDS--PAGE gels, placed in 96-well plates and washed extensively with HPLC water. Tryptic digestion was performed on a MassPrep liquid handling robot (Waters) according to the manufacturer's specifications and to the protocol of [@b0130] with minor modifications ([@b0065]). Briefly, proteins were reduced with 10 mM DTT and alkylated with 55 mM iodoacetamide. Trypsin digestion was performed using 126 nM of modified porcine trypsin (Sequencing grade, Promega) at 58 °C for 1 h. Digestion products were then extracted using 1% formic acid and 2% acetonitrile followed by 1% formic acid and 50% acetonitrile. The recovered protein extracts were pooled, vacuum centrifuge dried and resuspended into 10 μL of 0.1% formic acid. Aliquots of 2 (for cytosolic fractions) or 5 (for ME fractions) μL were analyzed by mass spectrometry.

2.5. Mass spectrometry for the ME fraction {#s0035}
------------------------------------------

SILAC experiments for the ME fraction were performed on a ABI QSTAR XL QqTOF mass spectrometer equipped with a nanospray II ion source (ABSciex) coupled to an Agilent 1100 HPLC as previously described ([@b0045]). Five microliters of each protein sample were injected by the Agilent 1100 autosampler onto a 0.075 mm (internal diameter) self-packed IntegraFrit column (New Objective) packed with an isopropanol slurry of 5 μm Jupiter C18 (Phenomenex) stationary phase using a pressure vessel set at 700 psi. The length of the column was 12 cm. Samples were run using a 75 min gradient from 10--40% solvent B (solvent A: 0.1% formic acid in water; solvent B: 0.1% formic acid in acetonitrile) at a flow rate of 250 nL/min. An information-dependent acquisition (IDA) method was set up with the MS survey range set between 400 amu and 1600 amu (1 s) followed by dependent MS/MS scans with a mass range set between 100 and 1600 amu (3 s) of the 3 most intense ions with the enhanced all mode activated. Dynamic exclusion was set for a period of 15 s and a tolerance of 100 ppm.

2.6. Mass spectrometry for the cytosolic fraction {#s0040}
-------------------------------------------------

SILAC experiments for the cytosolic protein fraction were performed on a TripleTOF 5600 mass spectrometer equipped with a nanospray III ion source (ABSciex) coupled to an Agilent 1200 HPLC. Two microliter samples were injected by the Agilent 1200 autosampler onto a 0.075 mm (internal diameter) self-packed PicoFrit column (New Objective) packed with an isopropanol slurry of 5 μm Jupiter C18 (Phenomenex) stationary phase using a pressure vessel set at 700 psi. The length of the column was 15 cm. Samples were run using a 65 min gradient from 5--35% solvent B (solvent A: 0.1% formic acid in water; solvent B: 0.1% formic acid in acetonitrile) at a flow rate of 300 nL/min. Data were acquired using an ion spray voltage of 2.4 kV, curtain gas of 30 psi, nebulizer gas of 8 psi and an interface heater temperature of 125 °C. An information-dependent acquisition (IDA) method was set up with the MS survey range set between 400 amu and 1250 amu (250 ms) followed by dependent MS/MS scans with a mass range set between 100 and 1800 amu (50 ms) of the 20 most intense ions in the high sensitivity mode with a 2+ to 5+ charge state. Dynamic exclusion was set for a period of 3 s and a tolerance of 100 ppm.

2.7. Interpretation of tandem mass spectra and protein identification {#s0045}
---------------------------------------------------------------------

Raw data files (*n* = 40 for each sample) were submitted for simultaneous searches using the Protein Pilot version 4 software (ABSciex) utilizing the Paragon and Progroup algorithms ([@b0135]). The Protein Pilot program was set up to search the *L. infantum* proteins in the TriTrypDB LeishPEP database (<http://tritrypdb.org/common/downloads/release-4.0/Linfantum/fasta/LinfantumAnnotatedProteins_TriTrypDB-4.0.fasta>) with carbamidomethyl (C) as a fixed modification and standard SILAC (Lys +8, Arg +10) settings for QSTAR or TripleTof 5600 instruments. Proteins for which at least two fully trypsin-digested light (L) and heavy (H) peptides were detected at \>99% confidence and quantitative *p*-value lower than 0.05 were used for subsequent comparative quantitative analysis.

3. Results and discussion {#s0050}
=========================

Lipid formulations of the polyene antibiotic AmB are now the mainstay for the treatment of *Leishmania* in the epidemic region of Bihar in India where nearly 65% of the cases are refractory to the first line antimonial drugs ([@b0015; @b0050]). Although some sporadic unusual cases have been reported recently ([@b0145; @b0115]), clinical resistance has not yet threatened the efficacy of AmB, even when used through many courses as for treating HIV co-infected patients ([@b0075]). Using a SILAC-based quantitative proteomic method, we probed proteome alterations induced in an *in vitro* selected *L. infantum* AmB1000.1 resistant mutant. Since membrane proteins are often underrepresented in proteomic studies, we choose to analyze SILAC-labeled membrane enriched (ME) and cytosolic proteins separately in order to increase the proteome coverage.

The *L. infantum* AmB1000.1 resistant mutant was grown in the presence of ^13^C~6~-^15^N~4~-[l]{.smallcaps}-arginine and ^13^C~6~-^15^N~2~-[l]{.smallcaps}-lysine while the parental *L. infantum* WT strain was maintained in the same medium containing normal isotopic abundance amino acids. Both cell populations were counted and mutant parasites were mixed with WT cells in a 1:1 ratio. ME and cytosolic fractions were extracted from the mixed population and both fractions were independently subjected to SDS--PAGE separation. Each sample line was further fractionated into 40 pieces of gel, proteins were gel extracted, trypsin digested and peptides were identified and quantified by mass spectrometry and isotopic quantification. Only protein identifications with differences in their expression level greater than 1.2-fold when comparing mutant and WT levels were considered as significant. This expression threshold was selected after having performed a control experiment to evaluate the extent of isotopic incorporation and technical noise. A fold change of 1.2 was considered as an expression threshold well above background. Thus, 99 protein identifications corresponding to 97 individual proteins were assigned as differentially expressed in the AmB1000.1 mutant ([Table 1](#t0005){ref-type="table"}). Among them, 83 (84%) were up-regulated and 16 (16%) were down-regulated. Two proteins (*LinJ.03.0190* and *LinJ.24.1700*) were identified independently in both ME and cytosolic fractions as indicated in [Table 1](#t0005){ref-type="table"}. With only two exceptions (*LinJ.23.0880* and *LinJ.32.0280*), all the cytosolic proteins identified in this study were predicted to be devoid of transmembrane domains (TMDs) according to the TMHMM v2.0 algorithm ([Table 1](#t0005){ref-type="table"}). In contrast, a quarter (23%) of the proteins differentially expressed in ME fraction were predicted to have at least one TMD. The identification of proteins with no predicted TMD in ME fraction might be possibly explained by non-covalent interactions with components of membranes through hydrogen bonding, van der Waals contacts or electrostatic attractions. These types of interactions are known to play critical roles in maintaining cell membrane structure and facilitating membrane functions (reviewed in [@b0110]).

Differentially expressed proteins with statistical significance were sorted into functional classes according to GeneDB annotations and Gene Ontology. Metabolism (27%) and transcription/translation (26%) were the main functional classes represented in this study corresponding together to more than half of all the identified proteins ([Fig. 1](#f0005){ref-type="fig"}). Another quarter of the protein hits were represented by hypothetical proteins (13%) or involved in protein folding (12%) ([Fig. 1](#f0005){ref-type="fig"}). Other functional groups, each of which representing less than 5% of the identifications, were proteolysis, transport, cytoskeleton and surface proteins, whereas 9% of the identified proteins were not assigned to any of the aforementioned classes ([Fig.1](#f0005){ref-type="fig"}).

Three enzymes playing a role in the conversion of S-adenosyl-[l]{.smallcaps}-homocysteine to S-adenosyl-[l]{.smallcaps}-methionine, namely the S-adenosylhomocysteine hydrolase (*LinJ.36.4100*), cobalamin-dependant methionine synthase (*LinJ.07.0240*) and S-adenosylmethionine synthetase (*LinJ.30.3580*), were up-regulated in the AmB resistant mutant ([Table 1](#t0005){ref-type="table"}). Since S-adenosyl-[l]{.smallcaps}-methionine is involved in many cellular functions, including stress response, it may explain why this pathway was increased in the AmB mutant. Other key metabolic pathways detected in AmB1000.1 resistant mutant as being up-regulated included glycolysis with the hexokinase (*LinJ.21.0310*), fructose-1,6-bisphosphate aldolase (*LinJ.36.1320*), glyceraldehyde 3-phosphate dehydrogenase (*LinJ.30.3000*) and enolase (*LinJ.14.1240*) as well as the TCA cycle with the aconitase (*LinJ.18.0510*), GCVL-2 dihydrolipoamide dehydrogenase (*LinJ.32.3510*) and malate dehydrogenase (*LinJ.34.0150*) ([Table 1](#t0005){ref-type="table"}). Curiously, the succinate dehydrogenase flavoprotein (*LinJ.24.1700*), another enzyme involved in the TCA cycle, was found to be up-regulated in the cytosolic protein fraction (1.98-fold) but down-regulated in the ME fraction (1.90-fold). The reason for this discrepancy is unknown. The modulation of several glycolytic enzymes in an AmB resistance context is mimicking the glycolysis state level previously reported in *L. donovani* antimony *in vitro* resistant cell lines ([@b0020]) and may thus corresponds to a general stress response more than a specific drug response. However, the TCA cycle enzymes aconitase and malate dehydrogenase as well as the inositol phosphate metabolism enzyme myo-inositol-1-phosphate synthase were also found to be up-regulated in response to AmB in a previous *Candida albicans* proteomic study ([@b0070]), similarly as we observed here and thus might be involved in the AmB resistance phenotype acquired from our *in vitro Leishmania* mutant.

A number of enzymes part of the reactive oxygen species (ROS) induced pathway was overproduced in our AmB mutant namely the trypanothione reductase (TR) (*LinJ.05.0350*) as well as two different tryparedoxin peroxidases (TPX) (*LinJ.15.1100* and *LinJ.23.0050*) ([Table 1](#t0005){ref-type="table"}). In addition to the tryparedoxin cascade which was previously shown to be up-regulated in AmB clinical unresponsive strain ([@b0115]), increased reduced thiols by an overproduction of TR in the AmB resistant parasites may also be involved in better antioxidant defense as it was already reported in the case of antimony resistance ([@b0170]). Nonetheless, transfection of these individual genes (encoding TR and TXP) did not lead to a resistance phenotype to AmB ([Table S1](#s0065){ref-type="sec"}) suggesting that if they are involved in resistance it must be a more subtle role. AmB has been proposed to kill *Aspergillus terreus* by inducing intracellular oxidation leading to lipid peroxidation and ultimately cell death ([@b0025]). Thus, TR and TXP might possibly act by interfering somehow with this cell death pathway. It is also interesting to note that the detoxifying enzyme SODB2 iron superoxide dismutase (*LinJ.32.1920*) was similarly overproduced in the AmB mutant. This enzyme is known in several other organisms to be modulated in response to oxidative stress ([@b0005]). Moreover, superoxide dismutase was also shown to protect *C. albicans* from oxidative damage caused by AmB ([@b0140]). However, transfection of *SODB2* failed to show a direct role for resistance to AmB ([Table S1](#s0065){ref-type="sec"}) and further work would be required.

Many proteins involved in protein folding, such as heat-shock proteins and chaperonins, were also found to be up-regulated in AmB1000.1 suggesting a putative role of these proteins in AmB resistance or tolerance. In particular, the heat shock protein 83-1 (Hsp83-1, *LinJ.33.0370*) was found up-regulated in the AmB resistant mutant compared to WT cells ([Table 1](#t0005){ref-type="table"}). This protein is a member of the Hsp90 family, which has been recently found to be a key player in AmB resistance in *A. terreus* ([@b0030]). Furthermore, Hsp60, some Hsp70 and S-adenosylmethionine synthetase were also found to be up-regulated in *C. albicans* in response to AmB through a proteomic screen ([@b0070]). The role of heat shock proteins in resistance in *Leishmania* has not been directly assessed by gene transfection however ([Table S1](#s0065){ref-type="sec"}).

AmB is known to bind to the membrane ergosterol of sensitive *Leishmania* strains, causing pore formation in the membrane and leakage of ions like K^+^ which results ultimately in cell death ([@b0060; @b0125]). The H1A-2 P-type H+-ATPase (*LinJ.18.1510*) was down-regulated in our AmB mutant. Pma1p, the orthologous protein in yeast, is involved in the regulation of intracellular pH by hydrogen efflux (reviewed in [@b0095]). We may therefore hypothesize that the down-regulation of this proton pump at the parasite cell surface might prevent H^+^ expulsion and thus might help maintaining the membrane potential gradient necessary to survive K^+^ leaking. Overexpression experiments did not lead to a phenotype, however ([Table S1](#s0065){ref-type="sec"}), so the gene product encoded by *LinJ.18.1510* cannot be considered *per se* as an AmB resistance gene but still can be a contributing factor to the high level of AmB resistance since its proton activity might be a futile waste of ATP in the presence of pores in the membrane, thus unnecessarily depleting the parasite of ATP. Further experiments such as inactivation of the gene are required to assess any role of this candidate in AmB resistance in *Leishmania*.

Overall, the genes coding for 18 candidate proteins being detected either as up- or down-regulated from our quantitative proteomic analysis were cloned in an episomal vector and transfected in *L. infantum* WT and AmB resistant mutant cells, respectively ([Table S1](#s0065){ref-type="sec"}). These genes were selected because literature data were indicating a potential role in drug resistance in other organisms or because some motifs of these proteins were suggesting a possible link with chemoresistance or drug tolerance. Transfection experiments failed to show any direct link with AmB resistance, however. Since multiple mutations can co-exist and lead to drug resistance in *Leishmania* ([@b0055; @b0120]), it remains to be tested if a combination of two or more genes may lead to AmB resistance when co-transfected in the same recipient cell. A large number of protein candidates (*n* = 97) differentially expressed in our mutant were discovered and some might be only related to a stress response and not to the drug itself. One possible approach to decrease the false-negative discovery rate in SILAC proteomic experiments would be to study more than one mutant and concentrate on recurrent mutations in independent mutants. This strategy has indeed improved the quality of our dataset in other large genomic scale studies ([@b0055; @b0120]).

In conclusion, this large-scale proteomic study of an *in vitro* AmB *Leishmania* resistant mutant allowed the identification of 97 individual differentially expressed proteins when compared to the parental sensitive strain. While the candidate proteins tested by transfection were not directly involved in AmB resistance, several of the proteins identified were observed independently either in *Leishmania* or fungus. It is thus possible that some of these putative candidates may form protein complexes in order to sustain resistance or that their involvement in resistance is more indirect.

Appendix A. Supplementary data {#s0065}
==============================

Supplementary Table S1
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![Functional assignment of proteins found differentially expressed by SILAC between *L. infantum* WT and AmB1000.1 mutant. Protein functional classification was based on GeneDB annotations and Gene Ontology.](gr1){#f0005}

###### 

MS/MS identifications of differentially expressed proteins in AmB1000.1 compared to WT in SILAC experiments.

  Systematic IDs                 Putative protein name                                                                        Unique peptides[a](#tblfn1){ref-type="table-fn"} (% sequence coverage)   Ratio AmB 1000.1/WT   *p*-value   Error factor   TMDs[b](#tblfn2){ref-type="table-fn"}   Fraction[c](#tblfn3){ref-type="table-fn"}
  ------------------------------ -------------------------------------------------------------------------------------------- ------------------------------------------------------------------------ --------------------- ----------- -------------- --------------------------------------- -------------------------------------------
  *Transport*                                                                                                                                                                                                                                                                                   
  LinJ.18.1510                   H1A-2 P-type H+-ATPase, putative                                                             15 (14.48)                                                               −2,51                 0,0130      2,02           8                                       M
  LinJ.25.1210                   ATPase beta subunit, putative                                                                18 (31.62)                                                               1,68                  0,0009      1,29           0                                       C
  LinJ.30.3660                   ATP synthase, epsilon chain, putative                                                        2 (16.57)                                                                2,25                  0,0892      4,28           0                                       C
                                                                                                                                                                                                                                                                                                
  *Surface*                                                                                                                                                                                                                                                                                     
  LinJ.10.0500                   GP63, leishmanolysin,metallo-peptidase, Clan MA(M), Family M8                                24 (27.38)                                                               −4,14                 0,0001      1,83           1                                       M
  LinJ.30.0930                   Amastin-like surface protein-like protein                                                    2 (4.05)                                                                 −2,61                 0,0897      5,65           4                                       M
                                                                                                                                                                                                                                                                                                
  *Cytoskeleton*                                                                                                                                                                                                                                                                                
  LinJ.19.0680                   Kinesin, putative                                                                            9 (8.70)                                                                 1,98                  0,0001      1,25           0                                       C
  LinJ.23.0720                   Kinesin, putative                                                                            5 (6.86)                                                                 1,78                  0,0167      1,50           0                                       M
  LinJ.30.0350                   Kinesin, putative                                                                            4 (6.39)                                                                 2,18                  0,0316      1,84           0                                       C
                                                                                                                                                                                                                                                                                                
  *Metabolism*                                                                                                                                                                                                                                                                                  
  LinJ.03.0190                   Delta-1-pyrroline-5-carboxylate dehydrogenase, putative                                      8 (13.39)                                                                1,26                  0,0417      1,25           0                                       M
  LinJ.03.0190                   Delta-1-pyrroline-5-carboxylate dehydrogenase, putative                                      10 (21.43)                                                               1,67                  0,0045      1,37           0                                       C
  LinJ.05.0350                   Trypanothione reductase                                                                      2 (5.50)                                                                 2,50                  0,0320      2,06           0                                       C
  LinJ.07.0240                   Cobalamin-dependant methionine synthase, putative                                            3 (2.24)                                                                 1,91                  0,0334      1,74           0                                       C
  LinJ.14.0680                   Fatty acid elongase, putative                                                                2 (5.63)                                                                 −2,22                 0,0936      4,47           6                                       M
  LinJ.14.1240                   Enolase                                                                                      9 (24.48)                                                                1,53                  0,0706      1,60           0                                       C
  LinJ.14.1450                   Myo-inositol-1-phosphate synthase                                                            2 (4.56)                                                                 1,91                  0,0975      3,57           0                                       C
  LinJ.15.1100                   Tryparedoxin peroxidase                                                                      10 (32.16)                                                               1,81                  0,0548      1,86           0                                       C
  LinJ.18.0510                   Aconitase, putative                                                                          26 (33.15)                                                               1,37                  0,0687      1,41           0                                       C
  LinJ.21.0310                   Hexokinase, putative                                                                         14 (31.42)                                                               1,85                  0,0036      1,42           0                                       C
  LinJ.21.1490                   Adenylate kinase, putative                                                                   2 (9.29)                                                                 −3,23                 0,0546      3,55           0                                       C
  LinJ.22.0190                   Carnitine palmitoyltransferase-like protein                                                  1 (2.22)                                                                 −4,34                 0,0560      5,19           0                                       M
  LinJ.23.0050                   Peroxidoxin, tryparedoxin peroxidase                                                         2 (8.41)                                                                 2,67                  0,0276      2,18           0                                       C
  LinJ.23.0860                   ERG10 3-ketoacyl-coa thiolase-like protein                                                   2 (7.26)                                                                 2,47                  0,0140      1,59           0                                       C
  LinJ.23.0880                   Acetyl-CoA synthetase, putative                                                              5 (7.63)                                                                 2,17                  0,0054      1,53           1                                       C
  LinJ.24.1700                   Succinate dehydrogenase flavoprotein, putative                                               6 (12.03)                                                                −1,90                 0,0147      1,49           0                                       M
  LinJ.24.1700                   Succinate dehydrogenase flavoprotein, putative                                               5 (9.56)                                                                 1,98                  0,0127      1,59           0                                       C
  LinJ.30.2920                   Aldehyde dehydrogenase, putative                                                             2 (3.59)                                                                 1,67                  0,0013      1,20           0                                       M
  LinJ.30.3000                   Glyceraldehyde 3-phosphate dehydrogenase, glycosomal                                         18 (41.83)                                                               1,60                  0,0048      1,35           0                                       C
  LinJ.30.3580                   S-adenosylmethionine synthetase                                                              5 (13.52)                                                                2,22                  0,0780      2,53           0                                       C
  LinJ.32.1920                   SODB2 iron superoxide dismutase, putative                                                    4 (11.54)                                                                2,41                  0,0959      5,46           0                                       C
  LinJ.32.3110                   Nucleoside diphosphate kinase b                                                              2 (13.91)                                                                1,60                  0,0462      1,58           0                                       M
  LinJ.32.3510                   GCVL-2 dihydrolipoamide dehydrogenase, putative                                              8 (17.44)                                                                1,62                  0,0086      1,40           0                                       C
  LinJ.34.0150                   Malate dehydrogenase                                                                         5 (18.30)                                                                1,55                  0,0526      1,56           0                                       C
  LinJ.35.1190                   NADH-dependent fumarate reductase, putative                                                  25 (23.98)                                                               1,40                  0,0033      1,23           0                                       C
  LinJ.36.1320                   Fructose-1,6-bisphosphate aldolase                                                           10 (23.99)                                                               1,64                  0,0073      1,38           0                                       C
  LinJ.36.4100                   S-adenosylhomocysteine hydrolase                                                             12 (25.63)                                                               1,54                  0,0547      1,55           0                                       C
                                                                                                                                                                                                                                                                                                
  *Protein folding*                                                                                                                                                                                                                                                                             
  LinJ.21.1330                   T-complex protein 1, delta subunit, putative                                                 11 (15.79)                                                               1,86                  0,0229      1,67           0                                       C
  LinJ.23.1460                   T-complex protein 1, gamma subunit, putative                                                 10 (18.51)                                                               1,58                  0,0161      1,39           0                                       C
  LinJ.26.1360                   Prefoldin-like protein                                                                       5 (27.84)                                                                1,62                  0,0522      1,63           0                                       C
  LinJ.28.3060                   Heat-shock protein hsp70, putative                                                           45 (38.59)                                                               1,55                  0,0004      1,24           0                                       C
  LinJ.30.2540                   Heat shock 70-related protein 1, mitochondrial precursor, putative                           42 (46.82)                                                               1,93                  0,0097      1,63           0                                       C
  LinJ.32.1060                   Chaperonin containing t-complex protein, putative                                            7 (11.71)                                                                1,95                  0,0053      1,47           0                                       C
  LinJ.32.1940                   Chaperonin Hsp60, mitochondrial precursor, putative                                          3 (5.05)                                                                 2,40                  0,0123      1,53           0                                       C
  LinJ.32.3470                   Chaperonin alpha subunit, putative                                                           20 (36.63)                                                               1,72                  0,0004      1,29           0                                       C
  LinJ.33.0370                   Heat shock protein 83-1                                                                      28 (26.86)                                                               1,52                  0,0042      1,31           0                                       C
  LinJ.33.2520                   Heat shock protein, putative                                                                 16 (17.98)                                                               1,52                  0,0172      1,39           0                                       C
  LinJ.36.2140                   Chaperonin Hsp60, mitochondrial precursor                                                    44 (54.98)                                                               2,14                  4,611E-06   1,21           0                                       C
  LinJ.36.7240                   Chaperonin, putative,T-complex protein 1 (theta subunit), putative                           13 (24.77)                                                               1,93                  1,289E-05   1,22           0                                       C
                                                                                                                                                                                                                                                                                                
  *Proteolysis*                                                                                                                                                                                                                                                                                 
  LinJ.09.0820                   Oligopeptidase b,serine peptidase, clan SC, family S9A-like protein                          4 (6.02)                                                                 1,56                  0,0870      1,72           0                                       C
  LinJ.11.0640                   Aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17                              7 (14.77)                                                                1,45                  0,0687      1,50           0                                       C
  LinJ.20.1220                   Calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative   3 (4.38)                                                                 −1,69                 0,0115      1,35           0                                       C
  LinJ.36.1730                   Proteasome beta 5 subunit, putative                                                          3 (11.92)                                                                1,86                  0,0438      1,78           0                                       C
                                                                                                                                                                                                                                                                                                
  *Transcription, Translation*                                                                                                                                                                                                                                                                  
  LinJ.01.0800                   Eukaryotic initiation factor 4a, putative                                                    10 (26.05)                                                               1,74                  0,0468      1,72           0                                       C
  LinJ.06.0410                   60S ribosomal protein L19, putative                                                          5 (15.92)                                                                1,21                  0,0238      1,17           0                                       M
  LinJ.09.1130                   Eukaryotic translation initiation factor 2 subunit, putative                                 2 (3.34)                                                                 2,02                  0,0191      1,70           0                                       C
  LinJ.11.0100                   Seryl-tRNA synthetase, putative                                                              3 (3.80)                                                                 2,17                  0,0064      1,55           0                                       C
  LinJ.13.0460                   40S ribosomal protein S12, putative                                                          8 (29.79)                                                                1,93                  0,0001      1,20           0                                       C
  LinJ.17.0110                   Elongation factor 1-alpha                                                                    23 (38.37)                                                               1,65                  0,0014      1,32           0                                       C
  LinJ.18.0740                   Elongation factor Tu, putative                                                               2 (5.59)                                                                 1,82                  0,0530      1,85           0                                       C
  LinJ.21.0600                   la RNA binding protein, putative                                                             5 (20.54)                                                                1,50                  0,0409      1,46           0                                       C
  LinJ.21.1310                   40S ribosomal protein S23, putative                                                          4 (18.88)                                                                1,32                  0,0324      1,26           0                                       M
  LinJ.25.0760                   Eukaryotic initiation factor 5a, putative                                                    2 (8.17)                                                                 2,27                  0,0497      2,27           0                                       C
  LinJ.26.2360                   60S ribosomal protein L35, putative                                                          4 (14.17)                                                                1,30                  0,0374      1,26           0                                       M
  LinJ.27.2480                   60S acidic ribosomal subunit protein                                                         3 (9.91)                                                                 2,17                  0,0166      1,55           0                                       C
  LinJ.29.1920                   40S ribosomal protein S15A, putative                                                         3 (20.77)                                                                2,00                  0,0659      2,18           0                                       C
  LinJ.30.3650                   40S ribosomal protein S14                                                                    4 (20.14)                                                                −1,43                 0,0057      1,20           0                                       C
  LinJ.32.0410                   ATP-dependent RNA helicase, putative                                                         17 (27.52)                                                               1,56                  0,0050      1,33           0                                       C
  LinJ.32.2850                   Ribosomal protein L27, putative                                                              6 (28.36)                                                                1,23                  0,0630      1,24           0                                       M
  LinJ.35.0240                   60S ribosomal protein L30                                                                    7 (56.73)                                                                1,92                  0,0236      1,70           0                                       C
  LinJ.35.1880                   60S ribosomal protein L5, putative                                                           5 (11.48)                                                                1,28                  0,0194      1,20           0                                       M
  LinJ.35.2000                   40S ribosomal protein S6, putative                                                           3 (4.02)                                                                 1,22                  0,0727      1,26           0                                       M
  LinJ.35.3840                   60S ribosomal protein L23, putative                                                          3 (25.90)                                                                2,19                  0,0433      2,07           0                                       C
  LinJ.35.5360                   Polyadenylate-binding protein 1, putative                                                    6 (9.11)                                                                 1,77                  0,0190      1,55           0                                       C
  LinJ.36.0020                   Histone H4                                                                                   5 (26.00)                                                                1,31                  0,0043      1,17           0                                       M
  LinJ.36.3950                   RPL10a 60S ribosomal protein L10a, putative                                                  6 (15.42)                                                                −1,31                 0,0863      1,39           0                                       M
  LinJ.36.4730                   RPL18 60S ribosomal protein L18, putative                                                    3 (13.13)                                                                −1,56                 0,0409      1,49           0                                       M
  LinJ.36.5870                   Isoleucyl-tRNA synthetase, putative                                                          5 (4.18)                                                                 1,96                  0,0566      2,03           0                                       C
  LinJ.36.7320                   Eukaryotic translation initiation factor 3 subunit 8, putative                               7 (6.16)                                                                 1,39                  0,0698      1,44           0                                       M
                                                                                                                                                                                                                                                                                                
  *Others*                                                                                                                                                                                                                                                                                      
  LinJ.14.0990                   Immunodominant antigen, putative,tc40 antigen-like                                           5 (6.97)                                                                 1,48                  0,0707      1,54           0                                       C
  LinJ.16.1710                   Prohibitin, putative                                                                         4 (16.42)                                                                −1,28                 0,0695      1,32           0                                       M
  LinJ.20.0820                   Vesicle-fusing ATPase, putative,N-ethylmaleimide-sensitive factor, putative                  5 (7.86)                                                                 1,55                  0,0832      1,68           0                                       C
  LinJ.23.0120                   GDP-mannose pyrophosphorylase                                                                3 (9.50)                                                                 1,88                  0,0683      2,06           0                                       C
  LinJ.28.2430                   Glycosomal membrane protein, putative                                                        4 (10.36)                                                                1,66                  0,0016      1,20           0                                       M
  LinJ.34.0720                   Flagellar attachment zone protein                                                            4 (10.92)                                                                1,88                  0,0676      2,02           0                                       C
  LinJ.34.2680                   Regulatory subunit of protein kinase a-like protein                                          9 (12.52)                                                                1,83                  0,0002      1,21           0                                       C
  LinJ.35.0070                   Prohibitin, putative                                                                         2 (6.16)                                                                 −1,71                 0,0182      1,43           1                                       M
  LinJ.36.3360                   14-3-3 protein-like protein                                                                  2 (8.53)                                                                 1,98                  0,0144      1,43           0                                       C
                                                                                                                                                                                                                                                                                                
  *Hypothetical*                                                                                                                                                                                                                                                                                
  LinJ.08.1010                   Hypothetical protein, conserved                                                              3 (8.77)                                                                 1,89                  0,0563      1,94           0                                       C
  LinJ.09.0120                   Hypothetical protein, conserved,calmodulin-like protein containing EF hand domain            6 (13.75)                                                                1,40                  0,0382      1,36           0                                       C
  LinJ.09.1070                   Hypothetical protein, conserved                                                              8 (15.93)                                                                1,53                  0,0699      1,60           0                                       C
  LinJ.09.1530                   Hypothetical protein, conserved                                                              2 (13.74)                                                                2,15                  0,0395      1,96           0                                       C
  LinJ.13.0740                   Hypothetical protein, conserved                                                              8 (9.88)                                                                 −2,13                 0,0222      1,82           0                                       C
  LinJ.16.1050                   Hypothetical protein, conserved                                                              3 (4.91)                                                                 −1,77                 0,0802      1,97           0                                       M
  LinJ.17.0780                   Hypothetical protein, conserved                                                              4 (5.21)                                                                 1,72                  0,0840      2,06           0                                       C
  LinJ.23.0810                   Hypothetical protein, conserved                                                              3 (3.96)                                                                 1,52                  0,0010      1,22           4                                       M
  LinJ.25.2100                   Hypothetical protein, conserved                                                              2 (7.87)                                                                 1,60                  0,0235      1,44           0                                       C
  LinJ.27.1220                   Hypothetical protein, conserved                                                              6 (9.64)                                                                 1,65                  0,0431      1,61           0                                       C
  LinJ.29.1570                   Hypothetical protein, conserved                                                              2 (3.23)                                                                 2,40                  0,0717      3,51           0                                       C
  LinJ.32.0280                   Hypothetical protein, conserved                                                              5 (4.07)                                                                 −1,59                 0,0650      1,68           2                                       C
  LinJ.36.5380                   Hypothetical protein, conserved; kinesin-like protein, putative                              7 (10.88)                                                                1,51                  0,0108      1,33           0                                       M

Peptide identifications were accepted if they reached greater than 95% probability as specified by the Peptide Prophet algorithm.

TMDs were predicted using TMHMM v2.0.

M, membrane-enriched fraction; C, cytosolic fraction.
